Vanta Bioscience has entered into an exclusive agreement with Hongkong Thinkway, Hong Kong to expand its business in the pre-clinical service sector in Greater China. The company has also entered into non-exclusive agreements to cover the markets of Latin America and Asia Pacific for Chemicals and Agro-chemical business.
These are lucrative markets and the Company expects over 25% at its revenues this year to come from this initiative.
Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
